Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
G1 Therapeutics is a biotechnology business based in the US. G1 Therapeutics stocks (GTHX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $23.98 – a decrease of 5.95% over the previous week. G1 Therapeutics employs 170 staff and has a trailing 12-month revenue of around $57.3 million.
Promoted
National Bank Direct Brokerage
Finder Award
Interactive Brokers
| Latest market close | $2.53 |
|---|---|
| 52-week range | $2.38 - $17.49 |
| 50-day moving average | $2.77 |
| 200-day moving average | $7.17 |
| Wall St. target price | $11.17 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.56 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $2.53 from 2023-06-01
| 1 week (2023-05-26) | -3.44% |
|---|---|
| 1 month (2023-05-02) | -14.81% |
| 3 months (2023-03-02) | -30.49% |
| 6 months (2022-12-02) | -58.93% |
| 1 year (2022-06-02) | -44.15% |
|---|---|
| 2 years (2021-05-29) | N/A |
| 3 years (2020-06-02) | 18.65 |
| 5 years (2018-06-01) | 43.6 |
| Revenue TTM | $57.3 million |
|---|---|
| Gross profit TTM | $47.6 million |
| Return on assets TTM | -37.86% |
| Return on equity TTM | -173.6% |
| Profit margin | -219.66% |
| Book value | $0.87 |
| Market capitalisation | $135.4 million |
TTM: trailing 12 months
We're not expecting G1 Therapeutics to pay a dividend over the next 12 months.
Over the last 12 months, G1 Therapeutics's shares have ranged in value from as little as $2.38 up to $17.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while G1 Therapeutics's is 1.9247. This would suggest that G1 Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
G1 Therapeutics, Inc. , a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing trilaciclib, a (CDK) 4/6 inhibitor can protect bone marrow and reduce hematologic adverse events (AEs), as well as improve emerging treatments through myeloprotection which improve patients' overall anti-tumor immune responses combination with the antibody-drug conjugate; and treatment of neoadjuvant breast cancer. In addition, the company develops lerociclib, an oral CDK4/6 inhibitor for multiple oncology indications; and rintodestrant, an oral selective estrogen receptor degrader, and HER2-negative breast cancer. The company has a license agreement with EQRx, Inc. and Genor Biopharma Co.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
